Brief: Outlook Therapeutics Reports Financial Results For FY 2024 And Provides Corporate Update
27/12/2024 15:24
Dec 27 (Reuters) - Outlook Therapeutics Inc OTLK.O :
* OUTLOOK THERAPEUTICS® REPORTS FINANCIAL RESULTS FOR FISCAL
YEAR
2024 AND PROVIDES CORPORATE UPDATE
* OUTLOOK THERAPEUTICS INC - COMMERCIAL LAUNCH OF LYTENAVA
IN UK
AND GERMANY EXPECTED H1 2025
Source text: ID:nGNX1FQc8G
Further company coverage: OTLK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Outlook Therapeutics
See all newsBrief: Outlook Therapeutics Appoints Kevin Lundquist As Chief Financial Officer As It Prepares For U.S. Commercial Launch Of Lytenava™
Outlook Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Outlook Therapeutics Q3 net loss narrows slightly as costs drop
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce